Search clinical trials for: General psychiatric intervention
Total 0 results
Nothing found
Sponsors and Collaborators
- HeartPoint Global
- Gulsah Ilhan
- Michael J. Wesley, PhD
- Center for Rare Neurological Diseases, Norcross, GA
- Frankel, Amylynne, M.D.
- Ana Paula Costella
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- IRCCS Don Gnocchi, Milano, Italy
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Pharmaspecific
- Manmohan Cardiothoracic Vascular and Transplant Center
- Laboratorios Viñas, S.A.
- Army Hospital, Percy
- Ruba Musharbash Nutrition Consultancy Center
- Korrus Inc.
- Edanz Group Japan Ltd
- Walgreens Co.
- Fundación Pública Andaluza Progreso y Salud
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- King Baudouin Foundation
- View Full List
Medical Conditions
- Cervical Cancer Stage IA2
- HPV-Related Anal Intraepithelial Neoplasia
- Child Physical Activity
- Any Injury or Illness Acutely Impacting Work
- Symptoms
- Synbiotics
- NR3C2
- Patients Who Had the Urine Volume at Nighttime More Than One Third of Total Daily Urine Volume (NPU) and Voided More Than Two Times at Nighttime (Nocturia)
- Rotator Cuff Lesion
- Mast-Cell Sarcoma
- Intensive Care Neuropathy
- Phenoxymethylpenicillin
- Stage IVA Lymphoepithelioma of the Oropharynx
- Autism or Autistic Traits
- Imaging, Diagnostic
- Learning Disturbance
- Nondepolarising Muscle Relaxants
- Serum Bank
- Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))
- Soft Tissue Sarcoma, Adult, Stage II
- View Full List
Drug Interventions
- CD25 treatment
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- Insulin
- 5-Fluorouracil
- Extended release guanfacine
- Miglustat
- Transdermal estradiol
- Interferon beta-1b (Betaferon, BAY86-5046)
- Apremilast
- LDEPA
- Ozanimod
- Thiotepa
- Methotrexate
- Exendin 9-39
- Rituximab plus CHOP
- Lidocaine/ ketamine
- Dexmedetomidine
- Interleukin-2
- FHND5071
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Germany
- Contract Research Organizations in Greece
- Contract Research Organizations in India
- Contract Research Organizations in Israel
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Norway
- Contract Research Organizations in Pakistan
- Contract Research Organizations in South Africa
- Contract Research Organizations in South Korea
- Contract Research Organizations in Togo
- Contract Research Organizations in Turkmenistan
- CRO list by country